Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-139407
Filing Date
2024-05-15
Accepted
2024-05-15 16:31:35
Documents
51
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d824064d10q.htm   iXBRL 10-Q 639510
2 EX-31.1 d824064dex311.htm EX-31.1 11489
3 EX-31.2 d824064dex312.htm EX-31.2 11480
4 EX-32.1 d824064dex321.htm EX-32.1 5589
5 EX-32.2 d824064dex322.htm EX-32.2 5565
  Complete submission text file 0001193125-24-139407.txt   3903160

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA blacu-20240331.xsd EX-101.SCH 41503
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE blacu-20240331_cal.xml EX-101.CAL 26022
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20240331_def.xml EX-101.DEF 184392
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20240331_lab.xml EX-101.LAB 240205
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20240331_pre.xml EX-101.PRE 233160
55 EXTRACTED XBRL INSTANCE DOCUMENT d824064d10q_htm.xml XML 455781
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41390 | Film No.: 24951747
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)